A class of HIV antiretroviral drugs known as CCR5 antagonists -- which includes maraviroc (Selzentry) and vicriviroc -- inhibit the invasion or spread of specific types of breast cancer cells that express CCR5 receptors, according to findings from a laboratory study published in the May 25, 2012, advance online edition of Cancer Research.
Click here for more info on the story
-
The untold Side of the movie "Dallas Buyers Club"
The movie Dallas Buyers Club brings attention to a little-recognized part of the AIDS activist movement: ....
-
Exhorbitant Price New Hepatitis C Drug
Fair Pricing Coalition Condemns Gilead Sciences on the High Price of New Hepatitis C Drug Sovaldi™...
-
Six Promising HIV Drugs in the Pipeline (2013-2014)
What new HIV medications do we have to look forward to over the next few years? How will these newer drugs improve upon the older ones? To shed some light on these questions....
-
What Can We Look Forward to in HIV Cure Research
TheBodyPRO.com's Nelson Vergel sat down with leading HIV cure research activist Richard Jefferys for an update on current important aspects, and controversies, in HIV cure research....
-
What Supplements Can I take with HIV medications?
Is it ok to supplement with Creatine (Cell-Tech), and Protein (Nitro-Tech) along with Glutamine...
Showing posts with label breast cancer. Show all posts
Showing posts with label breast cancer. Show all posts
Friday, June 15, 2012
Support PoWeR
Posts
